Cargando…

Incidence and risk of hypertension with lenvatinib in treatment of solid tumors: An updated systematic review and meta‐analysis

This meta‐analysis was performed to assess the relationship between Lenvatinib use for malignancy and hypertension (HTN). A total of 2483 patients met inclusion criteria. The relative risk (RR) for all‐grade and high‐grade (≧3) HTN were 2.61 (p ≦ .001) and 3.35 (p≦ .001), respectively, for Lenvatini...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hongxiao, Ding, Xiaoyan, Zhang, Yongchao, Li, Wei, Chen, Jinglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180318/
https://www.ncbi.nlm.nih.gov/pubmed/35538636
http://dx.doi.org/10.1111/jch.14463

Ejemplares similares